Skip to Content
Morningstar

Rydex Biotechnology H RYOAX

Morningstar Medalist Rating
Medalist Rating as of | See Rydex Investment Hub
  • NAV / 1-Day Return 57.26  /  +1.18 %
  • Total Assets 100.9 Mil
  • Adj. Expense Ratio
    1.640%
  • Expense Ratio 1.640%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield —
  • Turnover 61%

USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:18 PM GMT+0

Morningstar’s Analysis RYOAX

Will RYOAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable RYOAX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the RYOAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of RYOAX’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit Rydex Biotechnology H to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RYOAX

More RYOAX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 40.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

9.09 10.3 Mil
Healthcare

Amgen Inc

5.75 6.5 Mil
Healthcare

Regeneron Pharmaceuticals Inc

4.49 5.1 Mil
Healthcare

Vertex Pharmaceuticals Inc

4.20 4.8 Mil
Healthcare

Gilead Sciences Inc

3.66 4.1 Mil
Healthcare

Corteva Inc

3.17 3.6 Mil
Basic Materials

Moderna Inc

2.87 3.2 Mil
Healthcare

AstraZeneca PLC ADR

2.56 2.9 Mil
Healthcare

Biogen Inc

2.53 2.9 Mil
Healthcare

Illumina Inc

2.41 2.7 Mil
Healthcare